|
This report is part of a retrospective review and remediation efforts in response to a warning letter.Correction/removal number: z-0956-2020.(b)(4).S/w version 4.10e.The pump passed the displacement test, rewind test, prime/seating test, basic occlusion test, force sensor test, occlusion test, self test and displacement accuracy test.No unexpected pump error 54 or pump error 3 alarms noted during testing however, the formatted history file confirmed pump error 54 (line number 1421 file number 32122) and pump error 3 alarms due to a software error.The pump was connected to a test transmitter/sensor and monitored without any connection interruptions.Pump and test transmitter/sensor calibrated successfully.Pump was connected to a test meter, contour next link, and was able to connect.A controlled glucose test solution was tested using the meter and sent to the pump without any issues.No sg vs bg anomalies noted during testing.Displacement test: 0.03475, pass.Rewind test: pass.Prime/seating test: pass.Basic occlusion test: pass.Force sensor test: 2.75, pass.Occlusion test: 1.700, pass.Self test: pass displacement accuracy test: 0.08685, pass.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|